Jianhong Wang, PhD

I am an accomplished pharmaceutical scientist and founder of JW Pharma Consulting, with 25 years of experience in drug discovery and development. I have led DMPK and cross-functional teams, supporting IND- and NDA-enabling ADME programs across multiple therapeutic areas. I notably led the nonclinical team behind the NDA approval of Biktarvy®. Through my consulting practice, I advise biotech and pharma companies on development strategy, PK modeling, regulatory submissions, and due diligence, helping accelerate timelines, reduce risk, and maximize asset value.